Replies to post #40785 on Cel Sci Corporation (CVM)

[G8TSTFL]

You bring up many good points for a publication. It does put a bit of pressure on the FDA to approve, since going against a positive peer review would have to be justified. But, as with most of FDA’s hoops for approval, it just delays life saving medical care from the public with very little benefit.

Also I don’t think doctors will need much incentive to prescribe Multikine once it’s been deemed SOC.
I think that alone will be quite an endorsement.

[The_Q]

Simple reasoning

The shorts can’t spew false doubt on the peer review I’d the bla was accepted. If it’s good enough to present data to the fda then it’s good enough to raise the stock price